secwatch.observer — SEC 8-K summary
======================================

Issuer:     CalciMedica, Inc. (CALC)
CIK:        0001534133
Form:       8-K
Filed at:   2023-02-16T23:59:59+00:00
Accession:  0001193125-23-041092
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Graybug Vision enters $2M bridge loan with CalciMedica and amends merger terms
------------------------------------------------------------------------------

- Graybug agrees to lend CalciMedica up to $2M at 7.5% annual interest; initial $500K advanced.
- Amendment ensures outstanding loan principal and interest included in Graybug's net cash for merger closing.
- CalciMedica must use proceeds for payroll, rent, clinical trial, and regulatory costs; additional draws require Graybug approval.
- Merger termination triggers mandatory prepayment or credit against termination fees; three-month maturity after anniversary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534133/000119312523041092/0001193125-23-041092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534133/000119312523041092/d461698d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-041092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer